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IL-21 is a pleiotropic type 1 cytokine that shares the common
cytokine receptor γ-chain, γc, with IL-2, IL-4, IL-7, IL-9, and IL-15. IL-
21 is most homologous to IL-2. These cytokines are encoded by
adjacent genes, but they are functionally distinct. Whereas IL-2
promotes development of regulatory T cells and confers protec-
tion from autoimmune disease, IL-21 promotes differentiation of
Th17 cells and is implicated in several autoimmune diseases, in-
cluding type 1 diabetes and systemic lupus erythematosus. How-
ever, the roles of IL-21 and IL-2 in CNS autoimmune diseases such
as multiple sclerosis and uveitis have been controversial. Here, we
generated Il21-mCherry/Il2-emGFP dual-reporter transgenic mice
and showed that development of experimental autoimmune uve-
itis (EAU) correlated with the presence of T cells coexpressing IL-21
and IL-2 into the retina. Furthermore, Il21r−/− mice were more re-
sistant to EAU development than wild-type mice, and adoptive
transfer of Il21r−/− T cells induced much less severe EAU, under-
scoring the need for IL-21 in the development of this disease and
suggesting that blocking IL-21/γc–signaling pathways may provide
a means for controlling CNS auto-inﬂammatory diseases.
IL-21 is a type 1 four-α-helical-bundle cytokine with majoractions on a range of lymphoid populations (1). IL-21 signals
via IL-21R and the common cytokine receptor γ-chain, γc (1),
which is mutated in humans with X-linked severe combined
immunodeﬁciency (2) and is shared by the receptors for IL-2, IL-
4, IL-7, IL-9, IL-15, and IL-21 (3). IL-21 is produced mainly by
CD4+ T cells, including Th17 cells (1, 4), T follicular helper cells
(5), and natural killer (NK) T cells (6). It promotes the function
and expansion of effector CD8+ T cells (7) and can activate NK
cells (8). It is also critical for B-cell differentiation into plasma
cells and Ig production (9, 10) and negatively regulates the
function of dendritic cells (11). IL-21 plays a role in autoimmune
diseases, including type I diabetes in nonobese diabetic mice (12,
13), systemic lupus erythematosus in MRL/lpr and BXSB/Yaa
mice (9, 14, 15), and collagen-induced arthritis (16). In experi-
mental allergic encephalitis (EAE), divergent effects of IL-21
have been reported related to its role in the development and
progression of the autoimmune response as well as whether it is
required for disease development (1, 17, 18).
The genes encoding IL-21 and IL-2 are adjacent and share
similar genomic organization in humans and mice (19). Coevo-
lution of the IL-21 and IL-2 systems is further suggested not only
by their sharing of γc but also by the fact that IL-21R is most
closely related to IL-2Rβ (20); nevertheless, IL-21 and IL-2 have
distinct functions. For example, IL-21 is implicated in the de-
velopment of autoimmunity (9, 12–14, 16), but mice deﬁcient in
IL-2, IL-2Rα, and IL-2Rβ exhibit autoimmunity (21–24), sug-
gesting that IL-2 protects against development of autoimmune
disease. IL-21 can promote the development of Th17 cells,
whereas IL-2 inhibits the differentiation of Th17 cells (25), al-
though it induces the expansion of Th17 cells that mediate
uveitis and scleritis (26).
Uveitis is a group of sight-threatening idiopathic intraoc-
ular inﬂammatory diseases including Behçet’s disease, birdshot
retinochoroidopathy, sympathetic ophthalmia, Vogt-Koyanagi-
Harada, and ocular sarcoidosis, which may be of infectious or
autoimmune etiology (27). Experimental autoimmune uveitis
(EAU) shares pathological features with human uveitis, and
much of our understanding of the etiology and pathophysiology
of this disease derives from studies of EAU (27, 28). EAU can
be induced in susceptible rodent species by immunization with
the retinal protein, interphotoreceptor retinoid-binding protein
(IRBP) (Materials and Methods). Although the etiology of non-
infectious uveitis is unknown, patients with uveitis have more
IL-17–producing T cells (Th17) in peripheral blood than healthy
individuals (29). Moreover, Th17 cells increase during active
uveitis but decrease after treatment, suggesting that they play
a role in the disease process (26). Consistent with a role for Th17
cells in CNS autoimmune diseases, mice with targeted deletion
of the Stat3 gene in T cells cannot generate Th17 cells and do not
develop EAU or EAE (30), indicating the importance of Th17
cells in uveitis and multiple sclerosis. Because IL-21 is produced
by Th17 cells, mediates its biological actions in part via STAT3,
and promotes Th17 differentiation, IL-21 could be a potential
mediator of EAU.
An impediment to the study of the role of IL-21–expressing T
cells in disease has been the absence of high-quality Abs for
detecting in situ expression of IL-21 in tissues by intracellular
staining. In this study, we generated bacterial artiﬁcial chromo-
some (BAC) reporter transgenic (Tg) mice in which the pro-
moters of the adjacent Il2 and Il21 genes in a BAC clone
spanning both genes direct expression of emGFP and mCherry,
respectively. These mice allowed us to investigate in vivo the
presence of IL-21 (mCherry) and/or IL-2 (emGFP)–expressing
T cells in lymph nodes (LNs) and to monitor their inﬁltration
into the retina during EAU. We detected a substantial increase
in T cells expressing Il2-emGFP and Il21-mCherry in LNs before
the onset of inﬂammation, and these cells were subsequently
detected in the retina of mice with EAU, suggesting their in-
volvement in the pathogenic mechanism of uveitis. We also found
that Il21r−/− mice have defective development of EAU, and in-
volvement of IL-21 in this disease was further shown by adoptive
transfer experiments.
Results
Identiﬁcation of IL-21– and IL-2–Expressing Cells in Vivo Using Il21-
mCherry/Il2-emGFP Reporter Mice. To evaluate IL-21 and IL-2 gene
expression, we generated Il21-mCherry and Il2-emGFPBAC dual
reporter Tg mice (Fig. 1A). For most experiments, we used a
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founder line containing one integrated copy of the reporter con-
struct, but behavior of a second independent BAC reporter mouse
line was similar (Fig. S1 A and B). To validate the reporter mice,
we stimulated CD4+ T cells enriched from the Tg reporter and
wild-type (WT) littermatemicewith anti-CD3and anti-CD28 and
analyzed the expression of emGFP and IL-2 by ﬂow cytometry
(Fig. 1B). The frequency of IL-2+ cells determined by in-
tracellular staining was ∼35% in both Tg reporter mice and WT
controls. In the reporter mice, >95% of emGFP+ cells also pro-
duced IL-2, and ∼70% of IL-2–producing cells were emGFP+,
even though our ﬁxation procedure included paraformalde-
hyde, which can quench the emGFP ﬂuorecence. We also stim-
ulated CD4+ T cells with anti-CD3 + anti-CD28 and sorted
emGFP− and emGFP+ cells. By intracellular staining, 60% of
the emGFP+ but only 11% of emGFP− cells were IL-2+ (Fig.
S2A). Moreover, we evaluated IL-2 and IL-21 mRNA expression
of sorted emGFP−mCherry− double-negative (DN), emGFP+
and mCherry+ single-positive, and emGFP+mCherry+ double-
positive (DP) cells by real-time PCR. mCherry+ and DP cells
had ∼30-fold higher IL-21 mRNA expression than DN cells. As
expected, IL-21 mRNA expression in GFP+ cells was weaker.
emGFP+ cells had higher IL-2 mRNA expression than DN and
mCherry+ cells, and IL-2 mRNA expression of DP cells was less
than in GFP+ cells but still ﬁvefold higher than in DN cells (Fig.
1C). We also stimulated CD4+ T cells with anti-CD3 + anti-
CD28 with or without IL-6 and TGF-β for 18 h and evaluated
mRNA expression of mCherry, IL-21, emGFP, and IL-2 by
RT-PCR. Levels of mCherry and IL-21 mRNA were highly cor-
related (R2 = 0.99) as were emGFP and IL-2 mRNA (R2 = 0.89)
(Fig. 1D), further validating the Il2-emGFP/Il21-mCherry re-
porter mice.
We next stimulated CD4+ T cells with anti-CD3 + anti-CD28
under neutral conditions (presence of anti–IFN-γ + anti–IL-4)
versus Th1 or Th17 conditions and analyzed cells at days 1, 2,
and 3 (Fig. 1E). emGFP as a marker for IL-2 increased under all
conditions but least under Th17 conditions, whereas mCherry as
a marker of IL-21 production was highest in Th17 cells. As
expected, Th1 cells expressed both emGFP and mCherry, con-
sistent with their known production of IL-21 (1) as well as of
IL-2. Sorting of cells after Th1 stimulation revealed that ∼28.5%
of emGFP+ cells produced IFN-γ versus <2% of mGFP− cells
(Fig. S2B). Similarly, sorting of cells after Th17 differentiation
revealed that ∼11% of the mCherry+ cells produced IL-17A
versus <3% of mCherry− cells (Fig. S2C).
To identify IL-21– and IL-2–producing cells in vivo, we next
examined Il21-mCherry/Il2-emGFP expression in liver, spleen,
and other lymphoid tissues. CD4+ cells that expressed mCherry,
emGFP, or both were present in all tissues examined, but the
frequencies of the cell subsets differed in different tissues (Fig.
1F). Approximately 1–2% of CD4+ T cells in spleen, as well
as axillary, cervical, and mesenteric LNs, were Il2-emGFP+, in
contrast to ∼0.5% in the liver, whereas there were more of these
Fig. 1. Characterization of Il21-mCherry/Il2-emGFP reporter Tg mice. (A) Shown is a BAC containing the Il21 and Il2 genes, with mCherry and emGFP in-
troduced. (B) Splenic CD4+ T cells from control and reporter Tg mice were stimulated with anti-CD3 + anti-CD28 for 3 d, restimulated with PMA and ionomycin
for 4 h, and then surface-stained for CD4 and intracellularly stained for IL-2. The plots were gated on CD4+ cells. Shown is one of four experiments with similar
results. (C) mCherry−emGFP− DN, single-positive (mCherry+), emGFP single-positive (emGFP+), and mCherry+emGFP+ DP were sorted from CD4+ T cells from
the reporter Tg mice. IL-21 and IL-2 mRNAs were measured by real-time PCR. Data are from LNs pooled from 14 mice. (D) CD4+ T cells from reporter Tg mice
were not stimulated or were stimulated with anti-CD3 + anti-CD28, without or with IL-6, TGF-β, or both IL-6 and TGF-β for 18 h. IL-21, mCherry, IL-2, and
emGFP mRNAs were measured by RT-PCR. Correlation of IL-21 versus mCherry mRNA and of IL-2 versus emGFP mRNA expression are shown by R2 values.
Shown is one of two experiments with similar results. (E) CD4+ T cells from reporter Tg mice were polarized as indicated for 3 d. Shown are Il2-emGFP and Il21-
mCherry expression at days 1, 2, and 3. Shown is one of three experiments with similar results. (F) Il2-emGFP and Il21-mCherry expression in CD4+ T cells
isolated from reporter Tg mice or WT littermate controls. The bar graphs indicate data from gating on CD4+ T cells. ALN, axillary lymphocytes; CLN, cervical
lymphocytes; MLN, mesenteric lymphocytes; SI LPL, small intestine lamina propria lymphocytes. Shown is mean ± SD for three independent experiments. (G)
Splenocytes from reporter Tg mice were analyzed by ﬂow cytometry for expression of CD4, CD44, emGFP, and mCherry, gated on CD4+ T cells. Shown is one of
three experiments with similar results. (H) Expression of mCherry and emGFP is shown. (Upper) Gated on CD4+CD44highmCherry+ cells. (Lower) Gated on
CD4+CD44highemGFP+ cells. Shown is one of three experiments with similar results.
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cells (3–4% of CD4+ T cells) in the small intestine lamina
propria lymphocytes (SI LPLs) and in the colon LPLs, consistent
with higher basal stimulation in the gut (Fig. 1F, Top). For Il21-
mCherry, expression tended to be lowest in liver, axillary, and
cervical LNs, slightly higher in spleen, mesenteric LNs, and co-
lon, and highest (10% of cells) in SI LPLs (Middle). Cells
expressing both Il2-emGFP+ and Il21-mCherry were detected
in all tissues, but were highest in the gut (Bottom). Thus, Il2-
emGFP+ and Il21-mCherry+ cells were present in all immune
compartments examined, with relative enrichment in the in-
testine. Evaluation of splenic CD4+ T cells revealed that ∼80%
of these Il2-emGFP+ and Il21-mCherry+ cells were CD44hiCD4+
effector/memory type T cells (Fig. 1G). When we gated on
CD4+CD44+mCherry+ and CD4+CD44+emGFP+ cells, 39% of
Il21-mCherry+ cells and 38.6% of Il2-emGFP+ cells were both
mCherry+ and emGFP+ (Fig. 1H).
Augmented Expression of IL-21 and IL-2 Expression in EAU. We next
immunized the reporter Tg mice with IRBP and examined
mCherry and emGFP expression at day 21, at which point mice
had developed severe uveitis. After immunization, we detected
Il2-emGFP+ CD4+ T cells in draining LNs (Fig. 2 A and Left
Panel of B). mCherry also increased from 2% of CD4+ T cells
before immunization to ∼9% afterward (Fig. 2B, Center). After
immunization, ∼4% of CD4+ cells were Il21-mCherry+/Il2-
emGFP+ DP cells (Fig. 2B, Right). From 50,000 LN cells for
each sample, mCherry+ cells increased from ∼220 to ∼590 cells
after immunization. emGFP+ cells and DP cells increased from
∼200 to ∼500 and from ∼90 to ∼210 cells, respectively (Fig. 2C).
Similar results were obtained with a second reporter BAC Tg
mouse line containing six copies of the BAC clone rather than
one (Fig. S1). We also sorted DN, emGFP+, mCherry+, and DP
cells from CD4+-draining lymphocytes 21 d after immunization
Fig. 2. Increased Il2-emGFP and Il21-mCherry expression after EAU induction (A and B) Expression of Il2-emGFP and Il21-mCherry in draining lymphocytes
from reporter Tg mice 21 d after immunization with IRBP, gated on CD4+ cells. Shown are representative mice from one of two experiments with similar
results (n = 8 for Tg control and n = 6 for Tg EAU). (B) Summary of ﬂow cytometric proﬁles of CD4+ T cells from eight Tg control and six Tg EAU mice from the
experiment in A. Shown are Il2-emGFP+, Il21-mCherry+, and Il21-mCherry+Il2-emGFP+ DP cells. *P < 0.05. (C) From the experiment in A, 50,000 cells for each Tg
control and Tg EAU were analyzed. Shown are the number of mCherry+, emGFP+, and Il21-mCherry+Il2-emGFP+ DP cells. *P < 0.05. (D and E) mCherry− and
emGFP− DN, mCherry+, emGFP+, and mCherry+emGFP+ DP cells were sorted from CD4+ T cells from pooled LNs from reporter Tg mice 21 d after immunization
with IRBP. In D, IL-17A and IFN-γmRNAs were measured by real-time PCR. In E, cells were stimulated with PMA + ionomycin for 4 h, and IL-17A and IFN-γ were
measured by intracellular staining. (F) Frozen sections of LNs from reporter Tg mice 7 d after immunization were stained with DAPI. Red, mCherry; green,
emGFP. (G) Frozen sections of eyes from unimmunized and immunized reporter Tg mice at day 21. GCL, ganglion cell layer; INL, inner nuclear layer; ONL,
outer nuclear layer, RPE, retinal pigment epithelial layer. Shown is one of seven experiments with similar results.
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and performed both RT-PCR and intracellular staining. As
expected, mCherry+ cells had high Il17a mRNA expression (Fig.
2D), consistent with IL-17A cytokine production (Fig. 2E). Ifng
mRNA was expressed in emGFP+, mCherry+, and DP cells (Fig.
2D), and correspondingly, IFN-γ protein was produced by these
three populations (Fig. 2E). We also examined IL-21– and IL-2–
producing cells in draining LNs and retina using confocal mi-
croscopy and reporter Tg mice not immunized or immunized
with IRBP. Il21-mCherry and Il2-emGFP were expressed in
draining LNs at day 7 (Fig. 2F) and in the eye at day 21 after
immunization (Fig. 2G). Of the emGFP+ and/or mCherry+ cells
inﬁltrating the retina, ∼50% were Il2-emGFP+, ∼25% were Il21-
mCherry+, and ∼25% were DP cells (Fig. S3). Thus, during
EAU development, expression of both IL-2 and IL-21 was in-
duced in autoreactive CD4+ T cells, and cells expressing each
cytokine as well as cells expressing both cytokines were present in
the inﬂammatory cells inﬁltrating the retina.
Less Severe EAU in Il21r−/− Mice. Given the role of IL-21 in the
development of autoimmune diseases and its expression within
the retina, we investigated the development of EAU in WT
versus Il21r−/− mice, monitoring by fundoscopy from day 10 after
immunization to the end of the study period (approximately day
25). Compared with the normal control (Fig. 3A, Left), WT
retinas at day 21 showed severe inﬂammation with blurring of the
optic disk margins, retinal vasculitis with cufﬁng (red asterisks),
and inﬂammatory inﬁltrates (black arrows) (Fig. 3A, Center).
Histological analysis revealed massive inﬂammatory cell inﬁlt-
ration in the vitreous (black arrows), photoreceptor cell damage
and retinal folds (Fig. 3B, blue arrows), and choroiditis (Fig. 3B,
Center panels). In contrast, Il21r−/− mice had modest fundo-
scopic changes, with less inﬂammation, only slight retinal vas-
culitis with cufﬁng (red asterisk) (Fig. 3A, Right), and less severe
histological changes (Fig. 3B, Right panels). EAU scores based
on fundoscopy (31) (Fig. 3C) or histology (32) (Fig. 3D) showed
much less disease in the Il21r−/−mice. Correspondingly, at day 21,
the proliferation of draining LN cells from EAU WT mice was
greater than in unimmunized animals in response to IRBP (Fig.
3E). Proliferation was induced by immunization with IRBP in
Il21r−/− mice but was lower than in WT mice (Fig. 3E). IL-17–
expressing and IFN-γ–expressing T cells have been implicated in
EAU (26). We therefore examined the production of IL-2, IL-17,
and IFN-γ from CD4+ T cells in peripheral blood mononuclear
cells (PBMCs) after EAU induction. There was signiﬁcantly less
Fig. 3. Loss of IL-21 signaling protects mice from EAU. (A) Fundus images from C57BL/6 WT mouse (Left) and WT or Il21r−/−mice 20 d postimmunization with
IRBP (Center and Right). Red asterisks, retinal vasculitis with cufﬁng; black arrows, inﬂammatory inﬁltrates; blue asterisk, severe retinal inﬁltrates, choroiditis,
and vasculitis with cufﬁng. (B) Histological sections of eyes from WT and Il21r−/− mice 21 d post-IRBP. OpN, optic nerve; INL, inner nuclear layer; ONL, outer
nuclear layer; black arrows, inﬂammatory cells in vitreous; blue arrows, retinal fold. Shown is 1 of 10 mice with similar results. (C and D) EAU score of C57BL/6
WT and Il21r−/− mice based on fundoscopy (C) and histology (D). Shown is mean ± SEM of 10 mice in each group. *P < 0.05 (P = 0.0105). (E) LN cells from WT
and Il21r−/− control and EAU mice were cultured without or with IRBP in complete medium for 2 d and pulsed with [3H]thymidine for 12 additional hr. Shown
are mean ± SEM from ﬁve replicate cultures. *P < 0.01. (F and G) PBMCs fromWT and Il21r−/−mice were isolated 21 d after immunization and stimulated with
PMA + ionomycin for 4 h. Intracellular staining of IL-17A, IFN-γ, and IL-2 in CD4+ T cells was performed. (F) Data from one of three experiments with pooled
cells from three to four mice each. (G) Summary of the data from all three experiments (mean ± SD). (H) Cells from draining LNs at day 21 from IRBP-
immunized WT and Il21r−/− mice were stimulated with IRBP peptide for 3 d. IL-6, IL-1β, IL-10, and IL-17 levels in culture supernatant was measured by ELISA.
Data represent mean ± SD (n = 5 for IL-6, IL-1β, and IL-10 and n = 7 for IL-17A). N.S., P > 0.05 (P = 0.09). *P < 0.05.
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IL-17 and IFN-γ production in Il21r−/− mice, but IL-2 production
was similar in WT and Il21r−/− mice (Fig. 3 F and G). Moreover,
when draining LN cells were harvested at day 21 and then stim-
ulated with IRBP for 3 d, there was less IL-17A and IL-1β but
more IL-10 production in Il21r−/− mice (Fig. 3H). IL-6 produc-
tion tended to be lower, but the difference was not signiﬁcant
(Fig. 3H). Overall, these data indicate a possible shift from pro-
to anti-inﬂammatory cytokines in the absence of IL-21 signaling.
Adoptive Transfer of IRBP-Speciﬁc Uveitogenic Lymphocytes from
Il21r−/−Mice Induces Less Severe EAU than WT Cells. To conﬁrm that
the Il21r−/− mouse defect occurred in the generation of IRBP-
speciﬁc pathogenic T cells, we adoptively transferred WT and
Il21r−/− IRBP-speciﬁc lymphocytes into WT mice. We found
similar CD3 and CD4/CD8 proﬁles (Fig. 4A, Left and Center
panels), but the Il21r−/− cells produced less IL-17A and IFN-γ
but similar levels of IL-2 (Fig. 4A). Compared with mice re-
ceiving WT cells, animals receiving Il21r−/− cells exhibited less
severe EAU as evaluated by fundoscopy (Fig. 4B), histological
analysis (Fig. 4C), and clinical EAU score (Fig. 4D).
Discussion
In this study, we investigated the role of IL-21 in EAU de-
velopment. The expression of IL-21 in draining LNs and retina, as
revealed by the Il21-mCherry/Il2-emGFP reporter mice; the di-
minished development of EAU in I l21r−/−mice; and the less severe
EAU following adoptive transfer of IRBP-speciﬁc lymphocytes
from Il21r−/− mice together underscore the importance of IL-21 in
the development of EAU. WT mice mounted a higher IL-17 re-
sponse than did Il21r−/− mice. Given that IL-21 can promote Th17
cell differentiation (1), it is possible that the lack of IL-21 signaling
protects mice from EAU through a mechanism involving decreased
production of IL-17, which has been suggested to be important for
the development of both EAU (26, 29) and EAE (17). Previously,
IL-21 was shown to play important roles in animal models of type 1
diabetes (12, 13) and systemic lupus erythematosus (14, 15). Our
data now implicate this cytokine in a model of autoimmunity
causing disease at an immunologically “privileged” site as well,
revealing its very broad contribution to autoimmunity.
By analyzing the location of Il21-mCherry+ and Il2-emGFP+
cells after inducing EAU, we infer that immunization by IRBP
caused an immune response that produced both IL-21 and IL-2
in draining LNs, and both IL-21– and IL-2–producing cells were
located in the eye at day 21, when severe inﬂammation is evident.
Previously, IL-2 was reported to enhance protection from EAU
in part by stimulating production of anti-inﬂammatory cytokines
by regulatory T cells (33). The ability of IL-2 to inhibit Th17
differentiation (25) is another mechanism by which IL-2 might
inhibit EAU. The fact that there were both IL-2– and IL-21–
expressing cells in the inﬂammatory neuroretina in EAU is in-
teresting, as both overlapping and distinctive actions for these
cytokines have been noted (1, 34). Interestingly, IL-2 can expand
Th17 cells once developed, potentially promoting uveitis and
scleritis (26), and Daclizumab, a monoclonal antibody to IL-2Rα,
can control inﬂammation in patients with noninfectious uveitis
(35, 36), suggesting a role for IL-2 in the pathogenesis of this
disease. Our data showing the presence of IL-2/IL-21 double-
producer T cells in EAU extend these data.
In summary, we have shown a key role of IL-21 in the de-
velopment of EAU, suggesting that interfering with the action of
this cytokine may have therapeutic potential for uveitis. More-
over, we have generated Il21-mCherry/Il2-emGFP double re-
porter Tg mice to help study the role of IL-2 and IL-21 in the
pathogenesis of EAU. These mice may be valuable for studying
the potential roles for IL-2 and IL-21 in a broad range of other
disease models as well.
Materials and Methods
Mice. Il21r−/− mice (10) were produced by breeding heterozygous mice.
C57BL/6 mice were from the Jackson Laboratory. To generate Il2-emGFP/Il21-
mCherry Tg reporter mice, we used the RP23-98I15 BAC clone (Invitrogen),
which contains the Il21 and Il2 genes (Fig. 1A). Recombineering (37) was
used to introduce the emGFP (Invitrogen) and mCherry (38) coding
sequences linked to the SV40 poly(A) site into the ﬁrst exon of the Il2 and
Il21 genes, respectively. Recombineering comprises a two-step method to
create precise genetic changes: ﬁrst, amp-sacB is placed in the DNA and then
this is replaced with the emGFP or mCherry coding sequences in a second
recombineering event. The targeting cassettes with amp-sacB were ampli-
ﬁed using primers with ≥50 bp 5′ overhangs that were homologous to the
regions of the BAC just outside of the segment being replaced. The primers
Fig. 4. Il21r−/− mice are defective in generating IRBP-speciﬁc
pathogenic T cells. Draining LN cells from WT and Il21r−/−
EAU mice were stimulated with IRBP for 4 d and then
adoptively transferred into C57BL/6 WT mice. (A) WT and
Il21r−/− EAU mice were stimulated in vitro before adoptive
transfer. Percentage of CD3+ and CD4+ T cells are shown in
the ﬁrst two panels. We gated on CD4+ T cells and measured
the percentage of IL-17A–, IFN-γ–, and IL-2–producing cells
(last two panels). (B) Fundoscopy was performed 14 d later.
White arrows, inﬂammatory inﬁltrates; red asterisks, retinal
vasculitis with cufﬁng; blue asterisks, severe retinal inﬁltrates
and scars and choroiditis. (C) Histological sections of eyes of
EAU-adoptively transferred C57BL/6 WT mice, as indicated.
Blue arrows, retinal fold. (D) Shown is the EAU clinical score
of adoptive transfer EAU based on fundoscopy images by the
Mann–Whitney test. Shown is mean ± SEM. *P < 0.01. n = 4
mice in each group.
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are provided in SI Materials and Methods. BAC clones that had integrated
the targeting construct were selected, and the location of the insert was
conﬁrmed by PCR and sequencing. The BAC was prepped using a Large-
Construct kit (Qiagen), digested with NotI, DNA puriﬁed by phenol/chloro-
form extraction, and microinjected into fertilized C57BL/6J × CBA/J oocytes.
Resulting pups were screened for the emGFP and mCherry reporters by PCR
(see SI Materials and Methods for the primers). Founder lines were back-
crossed at least six generations to C57BL/6 mice. Experiments were per-
formed under protocols approved by the National Eye Institute and/or
National Heart, Lung, and Blood Institute Animal Care and Use Committees.
Analysis of CD4+ T-Helper Cells. For Th1 conditions, CD4+ T cells (>98% pure)
were treated with plate-bound 2 μg/mL anti-CD3 + soluble 1 μg/mL anti-CD28,
10 μg/mL anti–IL-4, and 10 ng/mL IL-12 for 3 d. For Th17 conditions, cells were
treated with anti-CD3/CD28, 20 ng/mL IL-6, 2 ng/mL TGF-β1, and 10 μg/mL each
of anti–IFN-γ and anti–IL-4. Cytokines and antibodies were from R & D Systems.
For intracellular cytokine detection, cells were stimulated for 4 h with 10 ng/
mL phorbol 2-myristate 3-acetate (PMA) + 1 μM ionomycin, Golgi-stop added
in the last 2 h, and intracellular cytokine staining performed using a Cytoﬁx/
Cytoperm kit (BD Pharmingen). Flow cytometry was performed using a FACS-
Calibur (BD Biosciences). All mAbs were from BD PharMingen. Flow cytometry
was performed on an LSRII (BD Biosciences). mCherry was detected using
a 561-nm laser with a 605/40 ﬁlter.
Real-Time PCR. mRNA was isolated from 106 cells (RNeasy mini kit; Qiagen)
and cDNA was prepared (Omniscript RT kit, Qiagen). Real-time PCR was
performed with an ABI PRISM 7700 sequence detection system with site-
speciﬁc primers and probes (Applied Biosystems).
Induction and Evaluation of EAU. Mice were immunized with 150 μg bovine
IRBP and 300 μg human IRBP peptide (amino acids 1–20) in 0.2 mL 1:1 vol/vol
emulsion with complete Freund’s adjuvant (CFA) containing Mycobacterium
tuberculosis strain H37RA (2.5 mg/mL). Mice simultaneously received 0.3 μg
Bordetella pertussis toxin. Clinical disease was scored by fundoscopy (31) and
histological analysis (32), as detailed in SI Materials and Methods. Tissue
sections were also examined using a multiphoton laser-scanning confocal
microscope with ﬂuorescence emission detected with 515/30 (emerald-GFP,
green) and 600/40 (mCherry, red), as described (26, 31). For adoptive transfer
experiments, draining LN cells from WT and Il21r−/− EAU mice (at day 21)
were stimulated with IRBP 20 μg/mL for 4 d, and 107 cells in 200 μL of PBS
were injected i.v. into sex- and age-matched recipient mice. Fundoscopic
examinations were performed 14 d after adoptive transfer.
Cytokine Analysis and Lymphocyte Proliferation Assays. A total of 5 × 106
draining LN cells were cultured for 3 d in medium containing 10 μg/mL IRBP
protein, and IL-6, IL-10, IL-1β, and IL-17 levels were measured using an ELISA
kit (BD PharMingen). For proliferation, normal control and EAU draining
lymphocytes (2 × 106/mL) were stimulated with 20 μg/mL IRBP. After 48 h,
cultures were pulsed with [3H]thymidine (0.5 μCi/10 μl/well) and incor-
poration was measured 12 h later.
Statistical Analyses. Nonparametric t tests and Prism software (Graphpad
Software) were used.
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